drugset / Trial / NCT03618797

A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

NCT03618797

Phase 3 Completed 347 enrolled Hanlim Pharm. Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Pitavastatin versus Pitavastatin/Fenofibrate in complex-dyslipidemia patients.

Timeline

Start
2015-11
Primary completion
2018-01
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 160 mg
Comparator Pitavastatin Small molecule 2 mg